|
BR9906712A
(pt)
*
|
1998-07-17 |
2000-10-10 |
Janssen Pharmaceutica Nv |
Péletes que apresentam um núcleo revestido com um antifúngico e um polìmero
|
|
ES2157731B1
(es)
*
|
1998-07-21 |
2002-05-01 |
Liconsa Liberacion Controlada |
Preparacion farmaceutica oral de un compuesto de actividad antifungica y procedimiento para su preparacion.
|
|
ES2251985T3
(es)
|
1999-03-24 |
2006-05-16 |
R.P. Scherer Technologies, Inc. |
Particula granulada para mejorar la solubilidad acuosa de farmacos, y su procedimiento de preparacion.
|
|
KR100432949B1
(ko)
*
|
2000-06-13 |
2004-05-31 |
코오롱제약주식회사 |
생체이용율이 향상된 이트라코나졸의 분립체 조성물과이를 이용한 이트라코나졸 제제 및 그 제조방법
|
|
US6663897B2
(en)
*
|
2001-02-06 |
2003-12-16 |
Dsm Ip Assets B.V. |
Oral itraconazole formulations and methods of making the same
|
|
ES2275866T3
(es)
|
2001-02-14 |
2007-06-16 |
Tibotec Pharmaceuticals Ltd. |
2-(aminosustituido)-benzotiazol-sulfonamidas de amplio esprecto inhibidoras de la proteasa de vih.
|
|
AR035819A1
(es)
|
2001-04-09 |
2004-07-14 |
Tibotec Pharm Ltd |
2-(amino sustituido)-benzoxazol sulfonamidas, inhibidoras de la proteasa del hiv, composiciones farmaceuticas que comprenden dichos compuestos, metodo in vitro para inhibir la replicacion retroviral y uso de dichos compuestos en la fabricacion de medicamentos
|
|
EA009590B1
(ru)
|
2001-05-11 |
2008-02-28 |
Тиботек Фармасьютикалз Лтд. |
2-аминобензоксазолсульфонамидные ингибиторы вич-протеазы широкого спектра
|
|
WO2002100407A1
(en)
*
|
2001-06-12 |
2002-12-19 |
Smartrix Technologies Inc. |
Itraconazole granulations: pharmaceutical formulations for oral administration and method of preparing same
|
|
US8071133B2
(en)
|
2001-08-20 |
2011-12-06 |
Stiefel Laboratories, Inc. |
Oral dosage forms of water insoluble drugs and methods of making the same
|
|
JP4578101B2
(ja)
|
2001-12-21 |
2010-11-10 |
テイボテク・フアーマシユーチカルズ・リミテツド |
幅広いスペクトルのｈｉｖプロテアーゼ阻害剤である複素環置換フェニル含有スルホンアミド
|
|
MY142238A
(en)
|
2002-03-12 |
2010-11-15 |
Tibotec Pharm Ltd |
Broadspectrum substituted benzimidazole sulfonamide hiv protease inhibitors
|
|
KR101019648B1
(ko)
|
2002-05-17 |
2011-03-07 |
티보텍 파마슈티컬즈 |
광범위 스펙트럼의 치환된 벤즈이속사졸 설폰아미드ｈｉｖ 프로테아제 저해제
|
|
JP4681296B2
(ja)
|
2002-08-14 |
2011-05-11 |
テイボテク・フアーマシユーチカルズ・リミテツド |
スペクトルの広い置換オキシインドールスルホンアミドｈｉｖプロテアーゼ阻害剤
|
|
KR100557680B1
(ko)
*
|
2002-11-23 |
2006-03-07 |
한국유나이티드제약 주식회사 |
이트라코나졸의 용해도 개선을 위한 펠렛제제 및 그제조방법
|
|
DK1438961T4
(da)
*
|
2003-01-14 |
2014-11-17 |
Acino Pharma Ag |
Bioækvivalent sammensætning af itraconazol dispergeret i en hydrofil polymer
|
|
EP1438960B2
(en)
*
|
2003-01-14 |
2012-12-19 |
Acino Pharma AG |
Compostion of itraconazole dispersed in a hydrophilic polymer having enhanced bioavailability
|
|
WO2005013939A1
(en)
|
2003-08-06 |
2005-02-17 |
Nirmal Mulye |
Pharmaceutical composition containing water soluble drug
|
|
UA84020C2
(ru)
|
2003-09-11 |
2008-09-10 |
Тиботек Фармасьютикелз Лтд. |
Ингибитор проникновения вируса вил
|
|
EP1568369A1
(en)
|
2004-02-23 |
2005-08-31 |
Boehringer Ingelheim Vetmedica Gmbh |
Use of meloxicam for the treatment of respiratory diseases in pigs
|
|
AR048650A1
(es)
|
2004-05-04 |
2006-05-10 |
Tibotec Pharm Ltd |
Derivados de (1,10b-dihidro-2-(aminocarbonil-fenil)-5h-pirazolo[1,5 c][1,3]benzoxazin-5-il)fenil metanona como inhibidores de la replicacion viral del vih
|
|
EP2422781A1
(en)
|
2004-05-07 |
2012-02-29 |
Sequoia Pharmaceuticals, Inc. |
Resistance-repellent retroviral protease inhibitors
|
|
CN1953982B
(zh)
|
2004-05-17 |
2011-07-06 |
泰博特克药品有限公司 |
4-取代-1,5-二氢-吡啶并[3,2-b]吲哚-2-酮
|
|
TW200607503A
(en)
|
2004-05-17 |
2006-03-01 |
Tibotec Pharm Ltd |
1-heterocyclyl-1, 5-dihydro-pyrido[3, 2-b]indol-2-ones
|
|
ES2351702T3
(es)
|
2004-05-17 |
2011-02-09 |
Tibotec Pharmaceuticals |
1-fenil-1,5-dihidro-pirido[3,2-b]indol-2-onas 6,7,8,9-sustituidas útiles como agentes farmacéuticos antiinfecciosos.
|
|
US7994187B2
(en)
|
2006-04-03 |
2011-08-09 |
Tibotec Pharmaceuticals Ltd. |
HIV inhibiting 3,4-dihydro-imidazo[4,5-B]pyridin-5-ones
|
|
CA2661172A1
(en)
*
|
2006-09-04 |
2008-05-29 |
Panacea Biotec Limited |
Programmable buoyant delivery technology
|
|
KR100809903B1
(ko)
*
|
2006-09-05 |
2008-03-06 |
주식회사유한양행 |
안정화된 클로피도그렐-함유 입자, 그의 제조방법, 및 이를포함하는 약학 조성물
|
|
CN101283984B
(zh)
*
|
2007-04-12 |
2010-05-26 |
永胜药品工业股份有限公司 |
高生物使用率的经杀真菌剂和聚合物涂覆的核心微粒状物
|
|
JP2008280254A
(ja)
*
|
2007-05-08 |
2008-11-20 |
Everest Pharm Industrial Co Ltd |
生体に使用される比率が高い、殺菌剤と重合物を塗粧してる核心微粒状物
|
|
US8313527B2
(en)
|
2007-11-05 |
2012-11-20 |
Allergan, Inc. |
Soft prosthesis shell texturing method
|
|
US8569364B2
(en)
|
2007-11-28 |
2013-10-29 |
Sequoia Pharmaceuticals, Inc. |
5-substituted benzofurans as inhibitors of cytochrome P450 2D6
|
|
US8906647B2
(en)
|
2008-02-21 |
2014-12-09 |
Sequoia Pharmaceuticals, Inc. |
Diamide inhibitors of cytochrome P450
|
|
US9050184B2
(en)
|
2008-08-13 |
2015-06-09 |
Allergan, Inc. |
Dual plane breast implant
|
|
US8877822B2
(en)
|
2010-09-28 |
2014-11-04 |
Allergan, Inc. |
Porogen compositions, methods of making and uses
|
|
US9205577B2
(en)
|
2010-02-05 |
2015-12-08 |
Allergan, Inc. |
Porogen compositions, methods of making and uses
|
|
US9138309B2
(en)
|
2010-02-05 |
2015-09-22 |
Allergan, Inc. |
Porous materials, methods of making and uses
|
|
SG174658A1
(en)
|
2010-04-01 |
2011-10-28 |
Theravida Inc |
Pharmaceutical formulations for the treatment of overactive bladder
|
|
JP5852640B2
(ja)
*
|
2010-05-11 |
2016-02-03 |
アラーガン、インコーポレイテッドＡｌｌｅｒｇａｎ，Ｉｎｃｏｒｐｏｒａｔｅｄ |
ポロゲン組成物、製造方法、および使用
|
|
US11202853B2
(en)
|
2010-05-11 |
2021-12-21 |
Allergan, Inc. |
Porogen compositions, methods of making and uses
|
|
US8679279B2
(en)
|
2010-11-16 |
2014-03-25 |
Allergan, Inc. |
Methods for creating foam-like texture
|
|
CN102100678B
(zh)
*
|
2011-02-18 |
2012-10-17 |
天津力生制药股份有限公司 |
伊曲康唑硫酸盐微丸及其制备方法
|
|
CA2895083A1
(en)
|
2012-12-13 |
2014-06-19 |
Allergan, Inc. |
Device and method for making a variable surface breast implant
|
|
US10092392B2
(en)
|
2014-05-16 |
2018-10-09 |
Allergan, Inc. |
Textured breast implant and methods of making same
|
|
WO2017127073A1
(en)
*
|
2016-01-20 |
2017-07-27 |
Theravida, Inc. |
Methods and compositions for treating hyperhidrosis
|
|
PT3781132T
(pt)
*
|
2018-04-16 |
2024-05-16 |
Pfizer |
Formulações de apixabano
|
|
CN114767636B
(zh)
*
|
2022-04-11 |
2023-11-07 |
苏州中化药品工业有限公司 |
伊曲康唑微丸、制备方法及伊曲康唑微丸胶囊
|